TP53 Mutation or Deletion and Efficacy with Single-Agent Lenalidomide in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) (CC-5013-CLL-009 Study) Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Buehler, Andreas
  • Wendtner, Clemens
  • Hallek, Michael
  • Kipps, Thomas J
  • Rassenti, Laura
  • Fraser, Graeme
  • Michallet, Anne-Sophie
  • Hillmen, Peter
  • Duerig, Jan
  • Gregory, Stephanie A
  • Kalaycio, Matt
  • Aurran-Schleinitz, Therese
  • Trentin, Livio
  • Purse, Brendan
  • Zhang, Jennie
  • Mei, Jay
  • Stilgenbauer, Stephan

publication date

  • November 15, 2013

published in